Skip to main content

Table 1 Antibacterial resistance of MRSA isolates, 1994–2004.

From: Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004

Year

Antibacterial resistance in MRSA (%)

 

#

Gm

Km

Sm

Em

Cm

Tet

Tp

Cip

Fa

Rf

MupH

Cd*

1994

342

98

100

100

66

25

94

86

53

22

1.0

ND

100

1995

298

95

98

100

89

25

92

87

23

45

1.4

ND

98

1996

421

100

100

100

68

44

94

93

41

32

3.0

6.0

100

1997

245

94

99

99

81

23

95

75

72

57

5.0

17

97

1998

329

88

95

77

74

21

92

61

63

75

3.0

24

94

1999

336

84

92

92

69

4.0

93

38

79

89

2.0

28

94

2000

542

86

95

94

76

3.0

89

34

72

81

8.0

22

98

2001

533

77

88

89

86

2.0

79

37

81

88

1.0

2.7

94

2002

883

85

95

89

88

4.0

90

16

96

90

5.0

3.0

93

2003

785

77

88

89

86

4.0

88

17

88

85

1.0

1.0

91

2004

930

81

89

86

88

2.0

88

27

92

92

4.7

4.7

89

  1. Abbreviations: #, number of isolates Gm, gentamicin, Km, kanamycin, Sm, streptomycin, Em, erythromycin, Cm, chloramphenicol, Tet, tetracycline, Tp, trimethoprim, Cip, ciprofloxacin, Fa, fusidic acid, Rf, rifampicin, MupH, high-level mupirocin resistance, Cd, cadmium acetate, also resistant to mercuric chloride, propamidine isethionate and ethidium bromide, ND, not detected